Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Laura Fernandez-Rodriguez"'
Autor:
Alfred Zippelius, Mélanie Buchi, Richard Klar, Julia Festag, Sven Michel, Frank Jaschinski, Sebastian Kobold, Abhishek S Kashyap, Johannes vom Berg, Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, Marcel P Trefny, Nicole Kirchhammer, Rainer H Kohler, Elham Jones, Andre Maaske, Karen O Dixon, Mikael J Pittet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
Background Although immune checkpoint inhibitors have been a breakthrough in clinical oncology, these therapies fail to produce durable responses in a significant fraction of patients. This lack of long-term efficacy may be due to a poor pre-existing
Externí odkaz:
https://doaj.org/article/78cf6c8515374d7f847b8913a986bde6
Autor:
Abhishek S. Kashyap, Laura Fernandez-Rodriguez, Yun Zhao, Gianni Monaco, Marcel P. Trefny, Naohiro Yoshida, Kea Martin, Ashwani Sharma, Natacha Olieric, Pankaj Shah, Michal Stanczak, Nicole Kirchhammer, Sung-Moo Park, Sebastien Wieckowski, Heinz Laubli, Rachid Zagani, Benjamin Kasenda, Michel O. Steinmetz, Hans-Christian Reinecker, Alfred Zippelius
Publikováno v:
Cell Reports, Vol 28, Iss 13, Pp 3367-3380.e8 (2019)
Summary: Dendritic cell (DC) activation is a critical step for anti-tumor T cell responses. Certain chemotherapeutics can influence DC function. Here we demonstrate that chemotherapy capable of microtubule destabilization has direct effects on DC fun
Externí odkaz:
https://doaj.org/article/21a0d97cff3b46a0a90aae9154512253
Autor:
Alfred Zippelius, Mélanie Buchi, Richard Klar, Julia Festag, Monika Schell, Sven Michel, Frank Jaschinski, Nicole Kirchhammer, Andre Maaske, Laura Fernandez Rodriguez, Stefanie Raith
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/8d9deaf4680c4b0188ce465ba98d44a2
Autor:
Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lötscher, Maryam Akrami, Jane C. Stinchcombe, Michal A. Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T. Jeker, Mohamed Bentires-Alj, Jérémie Rossy, Daniela S. Thommen, Gillian M. Griffiths, Heinz Läubli, Christoph Hess, Alfred Zippelius
Funder: Dr. Arnold U. und Susanne Huggenberger-Bischoff Stiftung zur Krebsforschung (Huggenberger-Bischoff Foundationfor Cancer Research); doi: https://doi.org/10.13039/501100007878
Funder: Krebsliga Beider Basel (Cancer League of Basel-City and
Funder: Krebsliga Beider Basel (Cancer League of Basel-City and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f479abc71d8dccd5face110935971b32
Autor:
Richard Klar, Clara Seger, Nicole Kirchhammer, André Maaske, Julia Festag, Laura Fernandez Rodriguez, Mélanie Buchi, Monika Schell, Stefanie Raith, Sven Michel, Alfred Zippelius, Frank Jaschinski
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, Marcel P Trefny, Richard Klar, Nicole Kirchhammer, Mélanie Buchi, Julia Festag, Sven Michel, Rainer H Kohler, Elham Jones, Andre Maaske, Abhishek S Kashyap, Frank Jaschinski, Karen O Dixon, Mikael J Pittet, Alfred Zippelius
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006714
BackgroundAlthough immune checkpoint inhibitors have been a breakthrough in clinical oncology, these therapies fail to produce durable responses in a significant fraction of patients. This lack of long-term efficacy may be due to a poor pre-existing
Autor:
Andre Maaske, Nicole Kirchhammer, Julia Festag, Laura Fernandez Rodriguez, Mélanie Buchi, Monika Schell, Stefanie Raith, Sven Michel, Richard Klar, Alfred Zippelius, Frank Jaschinski
Publikováno v:
Cancer Research. 82:4149-4149
Immune checkpoint inhibitors have become an important tool for the treatment of cancer. However, the majority of patients does not respond to the currently employed antibody-based treatments, indicating a need for additional targets and new treatment
Autor:
Michal A. Stanczak, Pankaj Shah, Naohiro Yoshida, Benjamin Kasenda, Nicole Kirchhammer, Abhishek S. Kashyap, Sung-Moo Park, Rachid Zagani, Sébastien Wieckowski, Laura Fernandez-Rodriguez, Gianni Monaco, Alfred Zippelius, Yun Zhao, Marcel P. Trefny, Hans Christian Reinecker, Ashwani Sharma, Michel O. Steinmetz, Kea Martin, Heinz Läubli, Natacha Olieric
Publikováno v:
Cell reports
Cell Reports, Vol 28, Iss 13, Pp 3367-3380.e8 (2019)
Cell Reports, Vol 28, Iss 13, Pp 3367-3380.e8 (2019)
SUMMARY Dendritic cell (DC) activation is a critical step for anti-tumor T cell responses. Certain chemotherapeutics can influence DC function. Here we demonstrate that chemotherapy capable of microtubule destabilization has direct effects on DC func
Autor:
Laura Fernández-Rodríguez, Rolindes Balda, Joaquín Fernández, Alicia Durán, María Jesús Pascual
Publikováno v:
Materials, Vol 15, Iss 9, p 3068 (2022)
In this study, glass-ceramics based on Sr2MgSi2O7 phosphor co-doped with Eu/Dy were obtained from the sintering and crystallisation of glass powders. The glasses were melted in a gas furnace to simulate an industrial process, and the dopant concentra
Externí odkaz:
https://doaj.org/article/3de7fe127fe64f1db91c4eba85693f51